Takeda

Contact
takedasd.com
+1858622-8528

Takeda San Diego, Inc.

10410 Science Center Drive
92121 San Diego
USA
+1858622-8528
takedasd.com
Contact
Profile News
Contact

About Takeda

Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer.

Read more about Takeda
Facts about Takeda
  • Industry : Pharma

News about Takeda

Takeda

01-Dec-2016 | business & finance

Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant

Takeda Pharmaceutical Company Limited announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine ...

Read news
Takeda

15-Oct-2015 | science

UCL and Takeda announce a new research partnership

Aims the identification of novel therapeutic targets for neurodegenerative diseases

Read news
Takeda

24-Jan-2011 | research and development

Evotec to Collaborate with Takeda Cambridge for Multi-target Hit Identification

Evotec AG  announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and ...

Read news
Takeda

24-Aug-2010 | research and development

Approval of Additional Indication of NESINA: Combination Therapy with Thiazolidinediones for Type 2 Diabetes in Japan

Takeda Pharmaceutical Company Limited announced that an additional indication for “NESINA®” (generic name: Alogliptin), combination therapy with ...

Read news
Takeda

31-Aug-2009 | research and development

Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin for Treatment of Type 2 Diabetes

Takeda Pharmaceutical Company Limited and Takeda Global Research & Development Center, Inc., a wholly owned United States subsidiary, jointly announced ...

Read news
Takeda

25-Aug-2009 | business & finance

Takeda Reacquires Rights to Diabetes Drug in Canada

Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, ...

Read news
Takeda

23-Apr-2008 | business & finance

Kinaxo Biotechnologies Enters Agreement with Takeda

Kinaxo Biotechnologies announced that it has entered an agreement with Takeda San Diego, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company ...

Read news
Show more news about Takeda

Here you will find Takeda San Diego, Inc.